Who is sponsoring NCT05713188?

NCT05713188 is sponsored by MediSieve Limited.

What drugs are being tested in NCT05713188?

Interventions in NCT05713188: MediSieve Magnetic Haemofiltration System.

What condition does NCT05713188 study?

NCT05713188 studies Haemofiltration.

Is NCT05713188 still recruiting?

NCT05713188 is currently completed. Last updated 6 February 2023.

Last reviewed 2023-02-06 · How we verify

NCT05713188

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Investigation of the Safety of the MediSieve Magnetic Haemofiltration System in Healthy Volunteers

Completed Phase 1 Last updated 6 February 2023

What this trial tests

Phase 1 trial testing MediSieve Magnetic Haemofiltration System in Haemofiltration in 6 participants. Completed in 30 November 2022.

Timeline

13 June 2022

Primary endpoint
17 November 2022

30 November 2022

Quick facts

Lead sponsor	MediSieve Limited
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	6
Start date	13 June 2022
Primary completion	17 November 2022
Estimated completion	30 November 2022
Sites	1 location across Netherlands

Drugs / interventions tested

MediSieve Magnetic Haemofiltration System

Conditions studied

Haemofiltration — all drugs for Haemofiltration →

Sponsor

MediSieve Limited

Who can join

Adults 18 to 50, any sex, with Haemofiltration. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a single-centre, non-randomised, prospective study to assess the safety of the MediSieve blood filtration system in healthy volunteers

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Preclinical and first-in-human safety studies on a novel magnetism-based haemofiltration method.
Waalders N, van Lier D, Gerretsen J, Moran L, et al · · 2024 · cited 3× · PMID 38890397 · DOI 10.1038/s41598-024-64379-9

Verify or expand the search:

Other trials of MediSieve Magnetic Haemofiltration System

Trials testing the same drug.

NCT03786536 — Safety and Initial Performance of the MediSieve Magnetic Haemofiltration System · NA · withdrawn

Other MediSieve Limited trials

Trials by the same sponsor.

NCT03786536 — Safety and Initial Performance of the MediSieve Magnetic Haemofiltration System · NA · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05713188 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by MediSieve Limited
Last refreshed: 6 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05713188.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing